2 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis Standard Varenicline Dosing (1 mg BID), Bupropion 150 mg twice daily, Increased Varenicline Dosing (1mg TID) - Pancreatitis, Chronic, Pancreatitis, Acute | Phase 2 | Withdrawn | Mayo Clinic | 2025-11-06 | 2026-07-07 | |
| Transcranial Direct Current Stimulation in a Smoking Cessation Trial active transcranial Direct Current Stimulation, sham transcranial Direct Current Stimulation - Nicotine Dependence | Phase 2 | Withdrawn | Centre for Addiction and Mental Health | 2016-10-01 | 2016-06-13 |
Behavior, Addictive (2) · Smoking Cessation (2) · Pancreatitis (1) · Pancreatitis, Chronic (1) · Smoking (1) · Tobacco Use Disorder (1)
Behavior (2) · Compulsive Behavior (2) · Health Behavior (2) · Chemically-Induced Disorders (1) · Chronic Disease (1) · Digestive System Diseases (1) · Disease Attributes (1) · Mental Disorders (1) · Pancreatic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Substance-Related Disorders (1)
BID protein, human (1) · Bupropion (1)
Centre for Addiction and Mental Health (1) · Mayo Clinic (1)
Canada (1) · United States (1)
Laurie Zawertailo, Ph.D. (1) · Samuel Han, MD (1)